Oliver, B., Haddow, L., Agarwal, U., Kumar, M., Easterbrook, P., Moosa, M., . . . Price, P. (2013). Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy.
Chicago Style (17th ed.) CitationOliver, B., L. Haddow, U. Agarwal, M. Kumar, P. Easterbrook, M. Moosa, S. Singh, and Patricia Price. Pre-antiretroviral Therapy Plasma Levels of CCL2 May Aid in the Prediction of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in HIV Patients After They Commence Antiretroviral Therapy. 2013.
MLA (9th ed.) CitationOliver, B., et al. Pre-antiretroviral Therapy Plasma Levels of CCL2 May Aid in the Prediction of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in HIV Patients After They Commence Antiretroviral Therapy. 2013.